Critics of the products welcomed the move but called for the FDA to take further action. "Today's action is an important step in the right direction, but FDA must do more to protect children" said Joshua Sharfstein, Baltimore's health commissioner, who led a petition to the FDA that prompted the review after four children died in Baltimore after taking the medications.
Full Article at San Francisco Chronicle